Old Web
English
Sign In
Acemap
>
Paper
>
Evaluating biologics and their biosimilars using a distributed research network to demonstrate real-world outcomes.
Evaluating biologics and their biosimilars using a distributed research network to demonstrate real-world outcomes.
2018
Pamala A. Pawloski
Kevin Haynes
Daniel J. Kent
Cheryl N. McMahill-Walraven
Catherine A. Panozzo
Vanita K. Pindolia
Catherine M. Lockhart
Jeffrey R. Brown
Aaron B. Mendelsohn
Charles E. Barr
Bernadette Eichelberger
Keywords:
Biosimilar
Risk analysis (engineering)
Computer science
real world outcomes
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]